Birgit Kräling

Nessuna posizione attualmente

Finance

Profilo

Birgit Kräling is responsible for monitoring the deal flow and the smaller stake investments.
Her core competencies are knowledge management, market and deal analysis, and technology scouting.
As a cell biologist with a focus on biomedical research in immunology and oncology, Dr. Kräling gained her scientific expertise through pre- and post-doctoral training in the U.S.
at The Wistar Institute (Philadelphia) and The Children's Hospital of Harvard Medical School (Boston), and as a research scientist at the Deutsches Krebsforschungszentrum (DKFZ; German Cancer Research Center) in Heidelberg.
In 2000, she joined the Innovation Team Biotechnology of Deutsche Bank AG in Frankfurt as a scientific relationship manager where she analyzed biotechnology companies and consulted on commercial banking activities in the German life science industry.
She joined HI in 2002.

Precedenti posizioni note di Birgit Kräling

Società	Posizione	Fine
Heidelberg Innovation Fonds Management GmbH Heidelberg Innovation Fonds Management GmbH Investment ManagersFinance Heidelberg Innovation Fonds Management GmbH (Heidelberg Innovation) is an independent German venture capital firm which was founded in 1997 by Dr. Ulrich Abshagen. In addition to providing financial capital, Heidelberg Innovation's 'network and knowledge capital', in the form of entrepreneurial experience, technical expertise and their network of experts and contacts, is a decisive added value for their investee companies. Based in Leimen, the firm manages the Heidelberg Innovation BioScience Venture II, Heidelberg Innovation Parallel Participation and the Heidelberg Innovation BioScience Venture I funds for investors including the European Investment Fund, insurance companies, banks, fund-of-fund investors and private individuals.	Analista di Private Equity	-

Vedi nel dettaglio l'esperienza di Birgit Kräling

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private